Quote:
Originally Posted by the urban politician
^ I not only have some patients who work for Abbvie, but I also personally know a few people who are “higher up” in that company, one of which is a former executive and she literally lives in Wisconsin!
|
I work with a few higher up executives who live in central Connecticut. Doesn't stop them still from coming in - although certainly where most people I'm working with are relocating cuts down on the commute for those people in CC
Quote:
The difference between Abbvie and McDonald’s is:
|
My post was less about Abbvie and more about the complexity of actually deciding on these relocations. I couldn't see a company like Abbvie moving to LY until there's a lot of stuff there anyway. Some companies do like to be in on the ground floor of areas like that though for various reasons, so you never know.
Quote:
What concerned me was when Takeda bailed for Boston. That shows that the suburban “talent pool” has some deficiencies that they obviously saw. If building a new & more competitive bio pharma ecosystem in the city can be achieved by Sterling Bay, Trammell Crow, and others, then I’m hoping for the best. Because I would hate to see more relocations for the coasts like that one.
|
Ultimately, it could be part of the entire equation when you really think about it. Older buildings that cost more to maintain with companies wanting more cutting edge labs which is easier to get in a few other cities (Boston, San Diego, etc). Also considering a diversity of experience levels and each company's plans on how to progress into the future. I do think what Sterling Bay, Trammell Crow, etc are doing is smart in the long run. If they attract the smaller fish to go into a few areas, they can basically build up life sciences areas where it'll be easier to attract the big, old companies to consider relocation.